Thursday, May 24, 2012
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?26 May 2011
White Papers
Focus Area: Business Strategies & IT
2 of 2
Previous |
Next
Business Strategies & IT
Benefit-Risk Communication Strategies: From Risk Communication Tools to Risk Minimization Action Plans
By Gary H. Slatko, MD, MBA – Chief Medical Officer, ParagonRx
No Comments
Streamlining regulatory publishing with submission-ready PDFs can add millions of dollars to the bottom line
By Scott Mackey
No Comments
How The Art of Project Management® Improved the Performance of Pharmaceutical Clinical Trials in a Major Global Pharmaceutical Company
By Thomas G. Johns, Ph.D., PE, PMP, MAPM, Senior Partner, Business Management Consultants (BMC)
No Comments
Next Generation Drug Safety: A Scientific Foundation for Greater Brand Success
Gary Slatko, MD, MBA Chief Medical Officer, ParagonRx
No Comments
2 of 2
Previous |
Next
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.